Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mathematical model predicts diabetes risk:

This article was originally published in Clinica

Executive Summary

A simple mathematical model that uses readily available clinical measurements could predict whether an individual is likely to develop type II diabetes as effectively as the standard glucose tolerance test, which is inconvenient and relatively expensive. The model, described in the Annals of Internal Medicine (April 16), uses information on a person's age, sex, ethnicity, and family history of diabetes and clinical factors such as high blood pressure, high cholesterol, and body weight.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT066070

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel